Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 196 AL 210

Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories

Butterfield DA.

Ageing Res Rev. 2020 Dec;64:101049. doi: 10.1016/j.arr.2020.101049. Epub 2020 Mar 20.

Extracellular Matrix Proteins Involved in Alzheimer's Disease

Ma J, Ma C, Li J, Sun Y, Ye F, Liu K, Zhang H.

Chemistry. 2020 Sep 21;26(53):12101-12110. doi: 10.1002/chem.202000782. Epub 2020 Jul 23.

There is no Failure, Only Discovery-the Year Ahead for CARving New Paths

Lahiri DK.

Curr Alzheimer Res. 2020;17(1):1-2. doi: 10.2174/156720501701200320143813.

Role of dietary fatty acids in microglial polarization in Alzheimer's disease

Desale SE, Chinnathambi S.

J Neuroinflammation. 2020 Mar 24;17(1):93. doi: 10.1186/s12974-020-01742-3.

APOE in Alzheimer's disease and neurodegeneration

Butterfield DA, Johnson LA.

Neurobiol Dis. 2020 Jun;139:104847. doi: 10.1016/j.nbd.2020.104847. Epub 2020 Mar 21.

Blood and Cerebrospinal Fluid Autoantibody to Aβ Levels in Patients with Alzheimer's Disease: a Meta-Analysis Study

Li XW, Li XX, Liu QS, Cheng Y.

J Mol Neurosci. 2020 Aug;70(8):1208-1215. doi: 10.1007/s12031-020-01528-5. Epub 2020 Mar 24.

Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F)

Li L, Kim HJ, Roh JH, Kim M, Koh W, Kim Y, Heo H, Chung J, Nakanishi M, Yoon T, Hong CP, Seo SW, Na DL, Song J.

Cell Prolif. 2020 Apr;53(4):e12798. doi: 10.1111/cpr.12798. Epub 2020 Mar 25.

A novel CNN based Alzheimer's disease classification using hybrid enhanced ICA segmented gray matter of MRI

Basheera S, Satya Sai Ram M.

Comput Med Imaging Graph. 2020 Apr;81:101713. doi: 10.1016/j.compmedimag.2020.101713. Epub 2020 Feb 28.

Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease

Arora D, Bhatt S, Kumar M, Vattikonda HDC, Taneja Y, Jain V, Joshi V, Gali CC.

Curr Pharm Des. 2020;26(27):3281-3299. doi: 10.2174/1381612826666200331085854.

Editorial: Alzheimer's Disease Drug Development Pipeline 2020

Sabbagh MN.

J Prev Alzheimers Dis. 2020;7(2):66-67. doi: 10.14283/jpad.2020.12.

Refractory epilepsy in PSEN 1 mutation (I83T)

Fray S, Rassas A, Messaoud T, Belal S.

Neurocase. 2020 Jun;26(3):167-170. doi: 10.1080/13554794.2020.1747632. Epub 2020 Apr 3.

Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins

Khan MS, Ikram M, Park JS, Park TJ, Kim MO.

Cells. 2020 Apr 1;9(4):853. doi: 10.3390/cells9040853.

[Pre-death grief in caregivers of Alzheimer patients. A validation of a guide]

Requena MDC, Suárez-Álvarez S.

Rev Esp Geriatr Gerontol. 2020 Jul-Aug;55(4):216-224. doi: 10.1016/j.regg.2020.02.001. Epub 2020 Apr 2.

γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase

Nie P, Vartak A, Li YM.

Semin Cell Dev Biol. 2020 Sep;105:43-53. doi: 10.1016/j.semcdb.2020.03.002. Epub 2020 Apr 2.

Synaptic plasticity in Alzheimer's disease and healthy aging

Cuestas Torres DM, Cardenas FP.

Rev Neurosci. 2020 Apr 28;31(3):245-268. doi: 10.1515/revneuro-2019-0058.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias